Tim F. Greten, MD

home / authors / tim-f-greten-md

Articles

Dr. Greten on the Tumor Microbiome and Antitumor Immunity in Liver Cancer

Tim F. Greten, MD

September 30th 2019

Tim F. Greten, MD, discusses the role of the gut microbiome in antitumor immunity in liver cancer.

Dr. Greten Discusses the Impact of the Gut Microbiome on Liver Tumors

Tim F. Greten, MD

December 12th 2018

Tim F. Greten, MD, senior investigator, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, discusses the impact of the gut microbiome on liver tumors.

Dr. Greten on Promising Immunotherapy Agents in HCC

Tim F. Greten, MD

May 19th 2017

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute, discusses promising immunotherapy agents being investigated in hepatocellular carcinoma (HCC).

Dr. Tim F. Greten on Immunotherapy in HCC

Tim F. Greten, MD

November 14th 2016

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute (NCI), discusses the potential for immunotherapy in hepatocellular carcinoma (HCC).